Denali Therapeutics won the 2026 “Best Biotechnology Product” award for AVLAYAH, giving the treatment added recognition. The report gives no sales or profit figures, so the business benefit is not yet shown.
The award adds recognition for AVLAYAH and its approach to reaching the brain. The report does not give sales or profit figures, so it cannot show how much the award may help Denali's business.
Follow Denali Therapeutics (DNLI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for DNLI